Nucleic acid encoding eotaxin
US6403782B1 · kind B1 · utility
34Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 4, 1999 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Aug 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is substantially pure eotaxin DNA sequence and eotaxin polypeptide, and methods of using such DNA and polypeptide to direct chemotaxis of eosinophils. Methods are provided for the treatment diseases and disorders such as inflammation and tumorigenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.